Stephanie Kirkner, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 Commons Blvd, Reading, PA 19605 Phone: 610-987-8543 |
Mrs. Jane Ellen Lawrence, MS-CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 Commons Blvd, Reading, PA 19605 Phone: 610-987-8541 |
News Archive
Initial results of a study conducted at 100 centers worldwide indicate that belatacept, a first-in-class costimulation blocker can prevent the immune system rejecting new organs. The results also suggest that it may provide similar patient and graft survival to cyclosporine but with fewer side effects and superior kidney function after 12 months. The study, published today in the American Journal of Transplantation, provides the first findings to come from BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial).
The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines -produced from healthy and tumour cells from the patient him or herself- and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.
Researchers from Karolinska Institutet and Kancera AB have developed a molecule that makes cancer cells sensitive to radiotherapy. In a study published in Nature Communications, the researchers describe a new way to block cancer cells' ability to repair their DNA and thus stop the survival of cancer cells.
Pregnant women and their partners have been advised to avoid travelling to the Wynwood Arts District of Miami after the zika virus was transmitted by local mosquitoes. This is the first time ever that the Centers for Disease Control (CDC) has issued a travel advisory relating to a part of mainland United States.
› Verified 2 days ago